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Background: CD72 is an inhibitory co-receptor expressed on B cells. We previously demonstrated significant
association of the polymorphism of the CD72 gene with susceptibility to human systemic lupus erythematosus
(SLE) in individuals carrying a SLE-susceptible FCGR2B genotype (FCGR2B-232Thr/Thr). The human CD72 locus
generates a splicing isoform that lacks exon 8 (CD72Δex8) as well as full-length CD72 (CD72fl), and the CD72
polymorphism regulates exon 8 skipping.
Results: Here we demonstrated that individuals carrying the disease-protective CD72 genotype exhibit significantly
lower serum immunoglobulin levels than do individuals carrying other CD72 genotypes (P < 0.05). Although
expression level of CD72fl in the peripheral blood B cells was similar regardless of CD72 genotype, the protein level
of CD72Δex8 was increased in individuals carrying the disease-protective CD72 genotype, suggesting a crucial role
of CD72Δex8 in regulation of antibody production. By expressing these human CD72 isoforms in mouse cell lines,
we further demonstrated that CD72Δex8 is accumulated in endoplasmic reticulum (ER) and fails to regulate BCR
signaling whereas human CD72fl is efficiently transported to the cell surface and inhibits signaling through the
B cell antigen receptor (BCR), as is the case for mouse CD72.
Conclusion: Human CD72 polymorphism appears to regulate antibody production as well as susceptibility to SLE
by regulating expression of ER-localizing CD72Δex8.
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CD72, a 45 kDa type II membrane protein expressed on
B cells, is an inhibitory co-receptor that regulates signal-
ing through the B cell antigen receptor (BCR) [1-6].
Both human and mouse CD72 contains a C-type lectin-
like domain in the extracellular region and an immunor-
eceptor tyrosine-based inhibition motif (ITIM) in the
cytoplamic region [1-3]. Mouse CD72 negatively regu-
lates BCR signaling by recruiting Src homology 2* Correspondence: tsubata.imm@mri.tmd.ac.jp
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reproduction in any medium, provided the ordomain-containing protein tyrosine phosphatase-1
(SHP-1) at ITIM [4-6]. However, the signaling function
of human CD72 remains unknown.
Four human CD72 polymorphisms have been identi-
fied in the upstream regulatory region and introns [7].
These CD72 polymorphisms constitute two major haplo-
types, CD72*1 and CD72*2. We previously demonstrated
that FCGR2B-Ile232Thr, a gene polymorphism of
FcγRIIb, is significantly associated with SLE in Asian
populations, and is a risk factor for SLE only in indivi-
duals with CD72*1/1 [7,8]. This finding indicates that
CD72*2 confers resistance to SLE in individuals carrying
FCGR2B-Ile232Thr. Two polymorphisms in intron 8
regulate generation of an alternative splicing isoformLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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act in combination as cis-acting intronic splicing enhan-
cer (ISE) or silencer (ISS) [7]. Exon 8 encodes the C-
terminal part of the C-type lectin-like domain and the
stop codon, and skipping of it results in replacement of
the C-terminal part of the C-type lectin-like domain by
a sequence encoded in exon 9 in CD72Δex8. The ratio
of mRNA level of CD72Δex8 to that of full-length CD72
(CD72fl) is strikingly higher in B cells from individuals
with the CD72*2/2 or CD72*1/2 genotype than in those
with CD72*1/1 [7]. Because there are no substitutions in
exons among different CD72 haplotypes, these findings
strongly suggest that increased CD72Δex8 level,
decreased CD72fl level, or both are responsible for the
resistance of CD72*2-carrying individuals to SLE.
In the present study, we addressed the functional
properties of CD72 isoforms. Analysis of healthy indivi-
duals revealed that those with CD72*1 express a signifi-
cantly lower level of the CD72Δex8 protein in B cells,
and show the higher level of serum immunoglobulins
than those carrying CD72*2, suggesting that CD72Δex8
regulates the immunoglobulin level as well susceptibility
to SLE. Analysis using B cell transfectants expressing
CD72Δex8 demonstrated that CD72Δex8 does not regu-
late BCR signaling but accumulates in the endoplasmic
reticulum (ER). Thus, the CD72 polymorphism regulates
antibody production and autoimmunity by modulating
the level of ER-localizing CD72Δex8.
Methods
Plasmids
cDNAs including the entire coding region of human
CD72fl or CD72Δex8 but not nucleotides for the stop
codon were obtained by RT-PCR from peripheral blood
mononuclear cells (PBMCs) with a pair of specific pri-
mers (50-GCA GAG CTG CTC AGG ACC AT-30 and
50-ACC CCA TTC TAC CAT GGG AA-30). The cDNAs
encoding CD72fl and CD72Δex8 were inserted with a
pair of oligonucleotides encoding FLAG-tag into the
retrovirus expression vector pMX-ires-GFP, and the
resulting plasmids were termed pMX-CD72fl and pMX-
CD72Δex8, respectively.
The retrovirus expression plasmids pMX-CD72flYF
and pMX-CD72Δex8YF encoding the mutants of CD72fl
and CD72Δex8, in which tyrosine7 is replaced by phenyl-
alanine, were generated by PCR-based site-directed mu-
tagenesis using a specific primer set (50- GCA GAT
CTG AGG TTT GTG AA -30 and 50- AAA GGT GAT
GGC CTC AGC CA -30).
Cells
The mouse B cell lines WEHI-231 and K46μv and the
human B cell line Raji were described previously [9,10],
and cultured in RPMI 1640 medium supplemented with10% FCS, 50 μM 2-ME, and 1 mM glutamine. The
mouse fibroblast cell line Balb/c-3T3 was cultured in
DMEM medium supplemented with 10% FCS and
1 mM glutamine. Retrovirus-mediated gene transfer was
performed as described previously [9].
PBMCs were obtained from unrelated healthy Japanese
living in the central part of Japan where genetic back-
ground is shown to be relatively homogeneous [11].
Informed consents were obtained from these indiciduals
prior to collecting samples. Peripheral B lymphocytes
were isolated from PBMCs by an autoMACS cell sorter
(Miltenyi Biotec, Auburn, CA) using the B cell isolation
kit II. This study was approved by the Research Ethics
Committees of the Graduate School of Medicine, The
University of Tokyo.
Genotyping
Human CD72 haplotype was determined by genotyping
CD72-VNTR, the tag polymorphism, by PCR-SSLP
method as described previously [7]. FCGR2B-Ile232Thr
was genotyped by nested PCR and fluorescence reson-
ance energy transfer (FRET) technology as described
previously [12].
Serum IgG level
Serum IgG levels in healthy individuals were measured
by turbidimetric immunoassay.
Flow cytometry
Peripheral blood B cells were incubated with FITC-labeled
anti-human CD72 mAb J4-117 (BD Biosciences, San Jose,
CA). B cell transfectants were incubated with rabbit anti-
FLAG Ab (Cell Signaling Technology, Danvers, MA), fol-
lowed by reaction with PE-labeled goat anti-rabbit IgG
(Southern Biotech, Birmingham, AL). Alternatively, trans-
fectants were stained with NP-conjugated PE. Cells were
then analyzed by flow cytometry using a FACSCalibur (BD
Biosciences).
Generation of anti-CD72Δex8 antibody
Rabbits were immunized with the peptide specific for
CD72Δex8 (Ala-Asp-Pro-His-Leu-Thr-Leu), and serum
IgG was purified from rabbit serum by ammonium sul-
fate precipitation. The specificity of the antibody was
confirmed by Western blotting of total cell lysates of
COS-7 CD72Δex8 transfectant using pre-immune and
immune serum.
Immunoprecipitation and Western blotting
Cells were stimulated with either 0.2 μg/ml NP15-coupled
BSA (NP-BSA) or 10 μg/ml anti-IgM Ab, and were lysed
in Triton X-100 lysis buffer [9,10]. Lysates were immuno-
precipitated with anti-FLAG Ab (Sigma-Aldrich, St. Louis,












































Figure 1 Serum IgG levels of healthy individuals. The
concentrations of serum IgG were measured by turbidimetric
immunoassay. CD72 IVS8-VNTR which was the tag polymorphism for
human CD72 haplotypes was genotyped by PCR–simple sequence length
polymorphism (SSLP) method, and FCGR2B-Ile232Thr was genotyped by
nested PCR and fluorescence resonance energy transfer (FRET)
technology. The concentrations of serum IgG were compared among
CD72 genotypes (A) or FCGR2B genotypes (B). The serum IgG levels were
compared among individuals with CD72*1/1, those with CD72*1/2 and
those with CD72*2/2 by Kruskal-Wallis rank sum test, and P-value indicates
the estimated probability of rejecting the null hypothesis that rank sum of
the serum IgG levels among different CD72 haplotypes are not different;
P < 0.05. Additionally, concordance to the model in which the serum IgG
levels are in proportion to the number of CD72*1 haplotype was
examined by regression analysis, and P-value indicates the estimated
probability of rejecting the null hypothesis that serum IgG levels were not
in proportion to the number of CD72*1 haplotype; P < 0.01.
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noprecipitates were separated on SDS-PAGE and were
transferred to polyvinylidene difluoride membranes. Mem-
branes were incubated with anti-phosphotyrosine mAb
4G10 (Millipore), anti-β-tubulin mAb TUB2.1 (Seikagaku
Kogyo, Tokyo, Japan), rabbit anti-FLAG Ab, rabbit anti-
CD72 Ab (Santa Cruz Biotechnology, Santa Cruz, CA),
rabbit anti-phospho ERK Ab (Cell Signaling Technology),
rabbit anti-SHP-1 Ab (Santa Cruz Biotechnology), or
rabbit anti-CD72Δex8 Ab. Proteins were visualized with
an ECL system.
Measurement of intracellular calcium mobilization
Cells were incubated in culture medium containing
5 μg/ml fluo-4-AM (Molecular Probes) for 30 min. Cells
were stimulated with 0.2 μg/ml NP-BSA, and were ana-
lyzed by flow cytometry using a FACSCalibur.
Assay of apoptotic cells
Cells were incubated with thapsigargin or staurosporine
for 24 h and 48 h, and cells containing hypodiploid
DNA were measured by flow cytometry [10].
Immunocytochemistry
Cells were fixed in 4% PFA for 15 min, washed with
PBS, and permeabilized with 0.1% Triton X-100 for
15 min. Cells were then washed with PBS, blocked with
2% BSA for 30 min, and stained for FLAG-tagged
human CD72 and organelle-specific marker proteins in
ER, mitochondria, Golgi apparatus, early endosomes,
and late endosomes using rabbit anti-FLAG Ab, anti-
KDEL mAb 10C3 (Stressgen, MI), anti-cytochrome C
mAb 6H2.B4 (BD Biosciences), anti-GM130 mAb 35
(BD Biosciences), anti-transferrin receptor mAb H68.4
(Invitrogen-Life Technologies), and anti-lamp1 mAb
1D4B (Southern Biotech), respectively. Cells were then
analyzed by laser scanning confocal microscopy (Model
LSM 510; Carl Zeiss Inc., Jena, Germany).
Statistical analysis
The serum IgG level among CD72 genotypes was ana-
lyzed using regression analysis and Kruskal-Wallis rank
sum test. Relative expression of CD72Δex8 protein prod-
uct between CD72 genotype was analyzed using Mann–
Whitney U test. Otherwise, Student’s t-test was used for
statistical analysis.
Results
Decreased serum immunoglobulin levels in CD72*2-carrying
individuals
To address whether the CD72 polymorphism regulates
humoral immunity, we measured the serum IgG levels
in 30 healthy volunteers. We genotyped CD72 IVS8-
VNTR which was the tag polymorphism for human
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morphism (SSLP) method [7], and there were the total
of 12 with CD72*1/1, the total of 16 with CD72*1/2, and
the total of 2 with CD72*2/2. The serum IgG level in-
versely correlated to the number of CD72*2 allele with
statistical significance (Figure 1A, regression analysis:
P<0.01; Kruskal-Wallis rank sum test: P<0.05). Addition-
ally, we genotyped FCGR2B-Ile232Thr by nested PCR
and fluorescence resonance energy transfer (FRET) tech-
nology in the same volunteers [12]. There was however
no significant difference in the serum IgG level among
FCGR2B-Ile232Thr genotypes (Figure 1B). Thus, CD72
polymorphism appears to play a role in the regulation of
antibody production.
Human CD72fl but not CD72Δex8 regulates BCR signaling
To assess the signaling function of both human CD72fl
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Figure 2 CD72fl but not CD72Δex8 is efficiently expressed on B cell s
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Representative data from three experiments are shown.vectors containing FLAG-tagged CD72fl, CD72Δex8 iso-
form, or their YF mutants in which the tyrosine residue
at ITIM was replaced by phenylalanine. Although BCR
ligation by antigen but not anti-Ig antibody induces effi-
cient mouse CD72-mediated BCR regulation through re-
cruitment of SHP-1, human B cell lines including Raji
and Ramos exhibited reduced SHP-1 expression [13],
and expressed endogenous CD72 and BCR with un-
known antigen specificity [14]. We therefore transduced
these retroviral vectors into the mouse B cell line K46μv,
which we used to examine the signaling function of
mouse CD72 because of its expression of BCR reactive
to the hapten (4-hydroxy-3-nitrophenyl) acetyl (NP)
without endogenous CD72 expression [9]. All the K46μv
transfectants expressed similar levels of NP-reactive
BCR (Figure 2A), and BCR ligation by a specific antigen
NP-BSA induced phosphorylation of extracellular signal-
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Figure 3 Protein level of endogenous CD72Δex8 is increased in
peripheral blood B cells in individuals with CD72*2. A: Levels of
cell surface expression of CD72 in individuals with each CD72
genotype. Peripheral blood B cells were isolated from 9 healthy donors
(three CD72*1/1, four CD72*1/2, and two CD72*2/2). Cell surface
expression was analyzed by flow cytometry using a FACSCalibur. B and
C: Expression of CD72Δex8 in B cells from individuals of each CD72
genotype and WEHI-CD72Δex8 transfectants. Peripheral blood B cells
were isolated from 7 healthy donors (four CD72*1/1, two CD72*1/2 and
one CD72*2/2) by autoMACS. Cells were lysed, and total cell lysates
were subjected to Western blot analysis using antibody specific to
CD72Δex8 (B). The same blots were reprobed with anti-β-tubulin Ab
to ensure equal loading. Levels of expression of CD72Δex8 were
standardized to that of β-tubulin. Data are shown in dot plots (C).
CD72Δex8 levels in peripheral blood B cells correlate to the number of
CD72*2 (P < 0.05; Mann–Whitney U test). Values are the mean ± SE.
Representative data from three experiments are shown.
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induced by antigen stimulation were decreased in K46μv
CD72fl transfectants compared to K46μv cells trans-
duced with vector alone (K46μv-vector) (Figure 2B, C),
indicating that CD72fl negatively regulates BCR signal-
ing. In contrast, neither ERK phosphorylation nor Ca2+
flux was decreased in K46μv transfectants that express
the YF mutant of CD72fl (CD72flYF) (Figure 2B, C), in-
dicating that CD72fl-induced BCR regulation depends
on its ITIM. Accordingly, CD72fl but not CD72flYF was
markedly phosphorylated and associated with SHP-1
after antigen stimulation (Figure 2D). Human CD72fl
thus negatively regulates BCR signaling in mouse B cells
by recruiting SHP-1 at the phosphorylated ITIM, as is
the case for mouse CD72 [4-6].
In K46μv transfectants, surface expression of
CD72Δex8 isoform was much lower than that of CD72fl
(Figure 2A), although the amount of CD72Δex8 in total
cell lysates was much larger than that of CD72fl
(Figure 2E), suggesting poor efficiency of transport of
CD72Δex8 to the cell surface. Equivalent ERK phosphor-
ylation and Ca2+ influx by NP-BSA treatment in K46μv
CD72Δex8 cells indicate that CD72Δex8 does not regu-
late BCR signaling. CD72Δex8 is thus poorly expressed
on the cell surface and does not regulate BCR signaling.
Increased CD72Δex8 expression in CD72*2-carrying
peripheral B-cells
Since the ratio of CD72Δex8 mRNA to CD72fl mRNA is
increased in B cells from CD72*2-carrying individuals re-
sistant to SLE [7], we next determined the protein levels of
endogenous CD72fl and CD72Δex8 in human primary B
cells. When we examined the surface expression of CD72
by flow cytometry using an anti-CD72 antibody that reacts
to both CD72fl and CD72Δex8, peripheral blood B cells
from healthy individuals carrying CD72*1/1, CD72*1/2, or
CD72*2/2 exhibited similar levels of surface CD72 expres-
sion (Figure 3A). This finding suggests that expression of
CD72fl does not differ among various CD72 haplotypes be-
cause CD72Δex8 is only poorly expressed on the surface.
To examine the CD72Δex8 level, we generated polyclonal
antibodies that recognize CD72Δex8 but not CD72fl, and
measured the protein levels of CD72Δex8 corrected for the
level of β-tubulin. The CD72Δex8 levels in peripheral
blood B cells carrying CD72*2 including both CD72*1/2
and CD72*2/2 were significantly higher than those carrying
CD72*1/1 (Figure 3B, C; CD72*1/1 vs. CD72*1/2 + *2/2,
Mann–Whitney U test: P < 0.05). Taken together, these
findings indicate that B cells carrying CD72*2, a haplotype
protective against SLE, express higher levels of CD72Δex8
whereas levels of CD72fl were similar regardless of the
number of CD72*2. Increase in the CD72Δex8 level is thus
responsible for CD72*2-mediated resistance to SLE, al-
though CD72Δex8 does not regulate BCR signaling.
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Since CD72Δex8 is poorly expressed on the cell surface,
we next examined the intracellular localization of CD72fl
and CD72Δex8 by confocal microscopy. In mouse B-cell
line WEHI-231 transfectants, CD72Δex8 was accumulated
inside the cells, though its location was unclear due to the
relatively small cytoplasm (Figure 4). To determine intra-
cellular localization in detail, we then transduced retroviral
vectors encoding CD72fl and CD72Δex8 into Balb/c-3T3
cells, which contain much larger cytoplasm than B lym-
phocytes. Fluorescence for CD72 was much stronger in
CD72Δex8 transfectants than in CD72fl transfectants, in-
dicating that CD72Δex8 is accumulated inside the cells
(Figure 5A). We therefore amplified the fluorescence in-
tensity of CD72fl to the levels of CD72Δex8, and com-
pared the intracellular localization of these proteins. Both
CD72fl and CD72Δex8 were localized in ER, mitochon-
dria, Golgi apparatus, early endosomes, and late endo-
somes, which are reasonable locations for membrane
proteins (Figure 5B). However, CD72Δex8 was strongly
accumulated in ER compared to CD72fl (Figure 5B).
Eukaryotic cells react rapidly to dysfunction of the ER
through a set of evolutionarily conserved adaptive path-
ways known as the unfolded protein response (UPR),
and persistent or intense ER stress triggers apoptosis
[15,16]. To obtain additional evidence for ER localization
of CD72Δex8, we addressed whether CD72Δex8 aug-
ments ER stress-mediated apoptosis. Expression of
FLAG-tagged CD72Δex8 but not CD72fl enhanced
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Figure 4 Localization of CD72Δex8 in WEHI-231 cells. Intracellular local
the relatively low fluorescence of CD72fl, its fluorescence intensity was amp
red. Proteins localized in ER (i,ii), mitochondria (iii,iv), Golgi apparatus (v,vi),
Cells were observed by confocal microscopy. Representative data are showcell line Raji induced by thapsigargin, which generates
ER stress by depletion of Ca2+ from ER [17] (Figure 6A,
B). In contrast, CD72Δex8 did not augment apoptosis of
WEHI-231 transfectants induced by treatment with
staurosporine, which induces apoptosis by mitochondrial
stress [18] (Figure 6C). Thus, CD72Δex8 specifically
enhances ER stress-induced apoptosis.
Discussion
Here we addressed humoral immunity and expression of
the two isoforms of human CD72, i.e., CD72fl and
CD72Δex8, in healthy individuals carrying different
CD72 haplotypes as the coding sequences of these iso-
forms were the same regardless of different CD72 haplo-
types. Individuals carrying higher numbers of CD72*2
allele showed lower serum levels of IgG, clearly demon-
strating association of, CD72*2 with low serum Ig as well
as reduced risk for SLE [7]. The cell surface expression
level of CD72fl on peripheral B cells was similar regard-
less of the number of CD72*2 allele. This is in agree-
ment with the previous study in which flow cytometry
demonstrated relatively homogeneous CD72 expression
on B cell surface in healthy individuals [19]. Thus, BCR
signal regulation mediated by CD72fl in B cells does not
differ among each CD72 genotypes because BCR regula-
tion appears to occur on the cell surface. In contrast,
Individuals carrying higher numbers of CD72*2 allele
showed higher levels of CD72Δex8 in peripheral B cells.
Although the sample size of this analysis is relatively
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ization of CD72fl and CD72Δex8 in WEHI-231 transfectants. Because of
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Figure 5 CD72Δex8 is accumulated in ER. A: Intracellular staining CD72 in Balb/c-3T3 transfectants. B: Intracellular localization of CD72fl and
CD72Δex8 in Balb/c-3T3 transfectants. Because of the relatively low fluorescence of CD72fl, its fluorescence intensity was amplified. Proteins
localized in ER (i, ii), mitochondria (iii, iv), Golgi apparatus (v, vi), early endosomes (vii, viii), and late endosomes (ix, x) are shown in green. CD72fl
and CD72Δex8 are shown in red. Cells were observed by confocal microscopy. Representative data from five experiments are shown.
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ratio of CD72Δex8 to CD72fl mRNA correlates to the
number of CD72*2 allele [7], and suggests that presence
of CD72*2 allele increases the protein level of CD72Δex8
but not CD72fl. Taken together, CD72Δex8 but not
CD72fl is responsible for difference in serum Ig and risk
for SLE among individuals carrying different CD72
genotypes.
We further examined the functional activity of CD72fl
and CD72Δex8, in signal regulation and cellular
localization by expressing these isoforms in mouse B cell
lines K46μv and WEHI-231, human B cell line Raji and
fibroblasts. As is the case for mouse CD72, CD72fl nega-
tively regulated BCR signaling in ITIM-dependent fash-
ion. In contrast, CD72Δex8 did not regulate BCR
signaling, probably due to its poor surface expression.
CD72Δex8 was accumulated in ER in fibroblasts and
augmented apoptosis induced by ER-stress in WEHI-231
and Raji, demonstrating ER localization of CD72Δex8.
Thus, ER-localizing CD72Δex8 is responsible for the
regulation of antibody production as well as susceptibil-
ity to SLE mediated by CD72 polymorphism.CD72Δex8 is generated by alternative splicing that
skips exon 8, causing replacement of an exon 8-encoded
stretch of 42 amino acids in the C-type lectin domain in
the extracellular region by a totally different sequence of
49 amino acids encoded by exon 9 [7]. This extensive
change in the extracellular C-type lectin domain may
cause accumulation of CD72Δex8 in ER. The change in
the C-type lectin domain may induce misfolding of the
CD72Δex8 protein, which causes ER retention of the
protein. Splicing isoforms of surface proteins such as
human FcγRIb, mouse glutamate receptor 7b (GluR7b),
and rat voltage-dependent and Ca2+−activated K+ chan-
nel (MaxiK) are mostly retained in the ER [20-22].
Whether these ER-localized isoforms play a role in cellu-
lar functions need to be elucidated in future studies.
We previously demonstrated that CD72*2 specifically
abrogates the susceptibility to SLE conferred by the al-
lele of FcγRIIb carrying the substitution of 232Ile by
232Thr (FCGR2B-Ile232Thr) [7], which is suggested to
reduce the inhibitory function of FcγRIIb [23]. FcγRIIb-
deficient mice exhibit loss of B cell self-tolerance at the
IgG+ B cell and plasma cell stages, and development of
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Figure 6 CD72Δex8 augments and ER stress-induced apoptosis
in the mouse B cell line WEHI-231 and human B cell line Raji. A
and B: Enhancement of apoptosis by CD72Δex8 in WEHI-231 (A)
and Raji (B). C: cells were stimulated with staurosporine. Apoptotic
cells containing hypodiploid DNA were analyzed by flow cytometry
using a FACSCalibur. Values are the mean ± SD of triplicate
determinations. *P < 0.01, **P < 0.001, ***P < 0.0001 (Student’s
t-test). Representative data from three experiments are shown.
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provides a distal peripheral checkpoint limiting the
accumulation of self-reactive plasma cells and thereby
preventing SLE. The Ile232Thr substitution may thus
reduce the activity of FcγRIIb in maintaining self-toler-
ance, and thereby increase risk for SLE. Our findings
suggest that CD72*2 augments apoptosis of B cells by
enhancing expression of CD72Δex8 (Figure 6). Augmen-
ted B cell apoptosis may reduce the number of self-
reactive B cells, and autoantibody-producing plasma
cells may not be generated at high frequency in CD72*2-
carrying individuals even in the presence of inefficient
self-tolerance caused by FCGR2B-Ile232Thr. Recently,over 30 loci were reported as the genes significantly
associated with susceptibility to SLE by genome-wide as-
sociation study (GWAS) [25]. However, most of these
loci carry very small effect, and the proportion of herit-
ability explained by these variants is modest [26,27].
Other than the effect of causal rare variant, it is possible
to explain a part of “missing heritability” by the gene-
gene interaction. This study, which shows the functional
interaction between CD72 and FCGR2B, will be a func-
tional evidence of such a gene-gene interaction.
Increasing numbers of studies have identified disease-
susceptibility alleles associated with specific splicing pat-
terns [28]. Our previous [7] and the present studies have
demonstrated that the genetic polymorphism of human
CD72 associated with susceptibility to SLE regulates the
efficiency of alternative splicing, although how the poly-
morphism affects alternative splicing is not known. Fur-
ther elucidation of the molecular mechanisms of splice
variations and their functional significance will provide
important clues to the pathogenesis of autoimmune dis-
eases and development of new therapeutic approaches.
Conclusion
Our finding that serum IgG levels in individuals carrying
the CD72*2 allele including both individuals with
CD72*1/2 and those with CD72*2/2 are significantly lower
than those in individuals carrying CD72*1/1 clearly
demonstrates that human CD72 polymorphism regulates
humoral immunity as well as risk for SLE [7]. Of the two
splicing isoforms of human CD72, CD72Δex8 appears to
be responsible for the regulation of Ig production and
autoimmunity, as the expression level of CD72Δex8 but
not the other isoform CD72fl is different between B cells
from individuals with CD72*2 and those with CD72*1/1.
Because CD72Δex8 is accumulated in ER and poorly
transported to the cell surface, CD72Δex8 may regulate B
cell activity by a mechanism distinct from CD72fl that is
expressed on the surface and regulate signaling through
BCR as is the case for mouse CD72. Although overexpres-
sion of CD72Δex8 enhances ER stress-induced apoptosis,
further studies are required to elucidate how CD72Δex8
in ER regulates B cell activity.
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